Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth
Topics: Research & Development, Drug Discovery, Rheumatology/Arthritis
|
PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis Event-Driven Update
Topics: Rheumatology/Arthritis
Regions: China
|
PharmaPoint: Rheumatoid Arthritis - Japan Drug Forecast and Market Analysis Event-Driven Update
Topics: Rheumatology/Arthritis
Regions: Japan
|
PharmaPoint: Rheumatoid Arthritis - Spain Drug Forecast and Market Analysis Event-Driven Update
Topics: Drug Discovery, Rheumatology/Arthritis
Regions: Spain
|
PharmaPoint: Rheumatoid Arthritis - United States Drug Forecast and Market Analysis Event-Driven Update
Topics: Drug Discovery, Rheumatology/Arthritis
Regions: United States
|
PharmaPoint: Rheumatoid Arthritis - Italy Drug Forecast and Market Analysis Event-Driven Update
Topics: Drug Discovery, Rheumatology/Arthritis
Regions: Italy
|
PharmaPoint: Rheumatoid Arthritis - Germany Drug Forecast and Market Analysis Event-Driven Update
Topics: Drug Discovery, Rheumatology/Arthritis
Regions: Germany
|
Baricitinib (Rheumatoid Arthritis) Forecast and Market Analysis
Topics: Drug Discovery, Rheumatology/Arthritis
|
Enbrel (Rheumatoid Arthritis) Forecast and Market Analysis
Topics: Drug Discovery, Rheumatology/Arthritis
|
Humira (Rheumatoid Arthritis) Forecast and Market Analysis
Topics: Drug Discovery, Rheumatology/Arthritis
|
Sirukumab (Rheumatoid Arthritis) Forecast and Market Analysis
Topics: Drug Discovery, Rheumatology/Arthritis
|
Remicade (Rheumatoid Arthritis) Forecast and Market Analysis
Topics: Drug Discovery, Rheumatology/Arthritis
|
Tabalumab (Rheumatoid Arthritis) Forecast and Market Analysis
Topics: Drug Discovery, Rheumatology/Arthritis
|
Masitinib (Rheumatoid Arthritis) Forecast and Market Analysis
Topics: Drug Discovery, Rheumatology/Arthritis
|
Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis
Topics: Drug Discovery, Rheumatology/Arthritis
|
Xeljanz (tofacitinib) (Rheumatoid Arthritis) Forecast and Market Analysis
Topics: Drug Discovery, Rheumatology/Arthritis
|
PharmaPoint: Rheumatoid Arthritis - France Drug Forecast and Market Analysis Event-Driven Update
Topics: Drug Discovery, Rheumatology/Arthritis
Regions: France
|
PharmaPoint: Rheumatoid Arthritis - United Kingdom Drug Forecast and Market Analysis Event-Driven Update
Topics: Drug Discovery, Rheumatology/Arthritis
Regions: United Kingdom
|
Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis
Topics: Drug Discovery, Rheumatology/Arthritis
|
Simponi (Rheumatoid Arthritis) Forecast and Market Analysis
Topics: Drug Discovery, Rheumatology/Arthritis
|
PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis Event-Driven Update
Topics: Rheumatology/Arthritis
Regions: Australia
|
Sarilumab (Rheumatoid Arthritis) Forecast and Market Analysis
Topics: Drug Discovery, Rheumatology/Arthritis
|
China Rheumatoid Arthritis Prescription Drug Sales Data 2006-2011
Topics: Manufacturing, Packaging & Detailing, Prescription Drugs, Rheumatology/Arthritis
Regions: China
|
Rheumatoid Arthritis – Pipeline Review, H2 2012
Topics: Arthritis, Drug Discovery, Rheumatology/Arthritis
|
The United States Rheumatic Diseases Therapeutics Market
Topics: Arthritis, Research & Development, Drug Discovery, Rheumatology/Arthritis
Regions: United States
|
United States Market for Rheumatoid Arthritis Pharmacotherapeutics
Topics: Manufacturing, Packaging & Detailing, Drug Discovery, Rheumatology/Arthritis
Regions: United States
|
Rheumatoid Arthritis Pipeline Perspectives Report - Direct Inflammatory Cytokine Blockers
Topics: Biologics, Research & Development, Drug Discovery, Rheumatology/Arthritis
|
Rheumatoid Arthritis Pipeline Perspectives Report - T-cell Activation Blockers
Topics: Biologics, Research & Development, Drug Discovery, Rheumatology/Arthritis
|
Rheumatoid Arthritis Pipeline Perspectives Report - Intracellular Signaling Blockers
Topics: Biologics, Research & Development, Drug Discovery, Rheumatology/Arthritis
|
Rheumatoid Arthritis Pipeline Perspectives Report - Non-Lymphocytic Inflammatory Cell Blockers
Topics: Biologics, Research & Development, Drug Discovery, Rheumatology/Arthritis
|
Rheumatoid Arthritis Pipeline Perspectives Report
Topics: Drug Discovery, Rheumatology/Arthritis
|
Rheumatoid Arthritis Pipeline Perspectives Report - Inflammatory Cytokine Production Inhibitors
Topics: Biologics, Research & Development, Drug Discovery, Rheumatology/Arthritis
|
Rheumatoid Arthritis Pipeline Perspectives Report - T-cell Migration Blockers
Topics: Biologics, Research & Development, Drug Discovery, Rheumatology/Arthritis
|
Rheumatoid Arthritis Pipeline Perspectives Report - B-cell Blockers
Topics: Biologics, Research & Development, Drug Discovery, Rheumatology/Arthritis
|
Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Topics: Pain, Osteoporosis, Drug Discovery, Rheumatology/Arthritis
|
The Rheumatoid Arthritis Community is Swelling with Anticipation as its Research Pipeline Begins to Burst
Topics: Arthritis, Research & Development, Rheumatology/Arthritis
|
Global Musculoskeletal Drugs Market 2011-2015
Topics: Pain, Research & Development, Orthopedics, Rheumatology/Arthritis
Regions: Global
|
Rheumatoid Arthritis Drugs Market in Japan 2011-2015
Topics: Research & Development, Prescription Drugs, Drug Discovery, Rheumatology/Arthritis
Regions: Japan
|
Prescribing Trends and Treatment Algorithms in Rheumatoid Arthritis
Topics: Research & Development, Drug Discovery, Rheumatology/Arthritis
|
Global Rheumatoid Arthritis Drugs Market 2011-2015
Topics: Research & Development, Prescription Drugs, Drug Discovery, Rheumatology/Arthritis
Regions: Global
|
Product Profiles: Disease Modification in Rheumatoid Arthritis – Game-changing therapy close to market
Topics: Biologics, Research & Development, Rheumatology/Arthritis
|
Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis Market to Decline with Patent Expiry of Celebrex in 2014
Topics: Orthopedics, Rheumatology/Arthritis
|
Rheumatoid Arthritis Adoption Insights
Topics: Research & Development, Drug Discovery, Rheumatology/Arthritis
|
China Rheumatoid Arthritis Prescription Drug Sales Data 2006-2010
Topics: Prescription Drugs, Rheumatology/Arthritis
Regions: China
|
Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Topics: Drug Discovery, Rheumatology/Arthritis
|
Rheumatoid Arthritis - Pipeline Review, H2 2011
Topics: Drug Discovery, Rheumatology/Arthritis
|
Rheumatoid Arthritis Market Forecast
Topics: Drug Discovery, Rheumatology/Arthritis
|
Rheumatoid Arthritis Market Forecast
Topics: Drug Discovery, Rheumatology/Arthritis
|
Rheumatoid Arthritis Market Forecast
Topics: Arthritis, Drug Discovery, Rheumatology/Arthritis
|
Market and Product Forecasts: Disease Modification in Rheumatoid Arthritis – Novel therapies plus reformulations poised to enter the market
Topics: Biologics, Research & Development, Drug Discovery, Rheumatology/Arthritis
|
